Acute Responses to a Potentiation Warm-up Protocol in Female Football Players.

August 12, 2024 updated by: University of Tromso

Acute Responses to a Potentiation Warm-up Protocol on Sprint and Change of Direction in Female Football Players: a Randomized Controlled Study

This study aims to determine if the performance of female football players is affected after exposure to a potentiation protocol. It is hypothesized that performance in the selected physical tests will improve significantly and meaningfully after performing the chosen potentiation protocol compared to the control group's warm-up.

Study Overview

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Famalicao, Portugal
        • Futebol Clube de Famalicão

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • players from any playing position (except goalkeepers) able to train without limitations.

Exclusion Criteria:

  • players with any existing medical conditions that could compromise participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Potentiation warm-up protocol with jumps combined with sprints with change of direction.
The intervention protocol consisted of i) 1st set - six hurdle jumps, with a distance of 70 cm between each, followed by a 15-m sprint with COD; (ii) 2nd set - six lateral hurdle jumps (three to the left and three to the right) followed by a 10-m sprint with COD; (iii) 3rd set - six bouncy strides, followed by a 15-m sprint with COD; (iv) 4th set - six broad jumps followed by a 10-m sprint with COD. All COD circuits had different configurations, changing the sprint distance and the angle of the COD curve. All repetitions and sets were separated by 90-second recovery intervals, and each set was performed three times.
Active Comparator: Control group
Usual warm-up exercises as previously used by the whole team.
The usual warm-up consisted of (i) The first phase included dynamic stretching and drills to increase body temperature. This phase lasted 5-min and included slow jogging, light skipping, and dynamic stretches for hip flexors, glutes, quads, hamstrings, abductors, gastrocnemius and lower limb joints. (ii) The second phase was composed of exercises that intended to mimic specific movements of the football match, both with and without ball possession. This phase lasted 15 minutes and included exercises with and without possession of the ball, such as acceleration, COD, jumping over hurdles, and playful games with ball possession. In this group, the players only rested in a slow jog when they moved from the first to the second phase.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agility T-test
Time Frame: First moment: beginning of the first training session; Second moment: at the end of the third week, after the fourth protocol session had been completed.
Used to determine speed with directional changes such as forward sprinting, left and right side shuffling.
First moment: beginning of the first training session; Second moment: at the end of the third week, after the fourth protocol session had been completed.
40-m sprint test
Time Frame: First moment: beginning of the first training session; Second moment: at the end of the third week, after the fourth protocol session had been completed.
After a 5 s countdown, the participants ran forward following the route marked by cones, one at 0m indicating the start place and the other at 40m indicating the finish place. Participants started the test from a standing start position with the front foot approximately 2 cm behind the first cone.
First moment: beginning of the first training session; Second moment: at the end of the third week, after the fourth protocol session had been completed.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Ivan Baptista, PhD, Faculty of Science and Technology, UiT The Arctic University of Norway

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Actual)

April 30, 2023

Study Completion (Actual)

April 30, 2023

Study Registration Dates

First Submitted

August 12, 2024

First Submitted That Met QC Criteria

August 12, 2024

First Posted (Actual)

August 15, 2024

Study Record Updates

Last Update Posted (Actual)

August 15, 2024

Last Update Submitted That Met QC Criteria

August 12, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Raw data used for the study will be available in a public repository.

IPD Sharing Time Frame

Raw data is already uploaded into a public repository and is intended to stay available without a date limit.

IPD Sharing Access Criteria

No access criteria will be established.

Study Data/Documents

  1. Individual Participant Data Set
    Information identifier: 10.17632/2cwcz2vx4v.1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletic Performance

Clinical Trials on Potentiation warm-up protocol

Subscribe